The aim of this study was to determine the impact of mean platelet volume (MPV) on the strategy for treatment of atrial fibrillation
(AF) with respect to stroke prevention.
MPV was analyzed in 265 patients with AF who were undergoing treatment using rhythm or rate control. The primary endpoint was
ischemic stroke or a transient ischemic attack (TIA) event.
Kaplan-Meier analysis revealed a significantly higher stroke rate in the rate control group compared to the rhythm control group. A significantly
higher stroke rate was observed in the higher tertile MPV group (≥7.9 fL) compared to the lower tertile MPV group (<7.3 fL).
When the MPV cut-off level was set to 7.85 fL using the receiver operating characteristic curve, the sensitivity was 80.0% and the specificity
was 70.4% for differentiating between the group with stroke and the group without stroke. In the Cox proportional hazard analysis,
after adjusting for sex, treatment strategy for AF, high MPV level, antithrombotic treatment, and high CHADS2 score, higher MPV, rate
control strategy for treatment of AF, and high CHADS2 score were found to be independent predictors of stroke risk. In addition, patients
with AF who were treated using rate control had high stroke risk with an MPV over 7.85 fL and high CHADS2 score.
The results of this study demonstrate that the MPV and the rate control strategy for treatment of AF were predictive markers for stroke;
its predictive power for stroke was independent of female sex and high CHADS2 score in patients with AF.